Stendo Laboratoire: innovative technologies for the health and well-being of individuals
In 2011, the president of the company, Jürg SCHEIWILLER, created STENDO® with Renan LE BLE, the managing director, in order to launch a new treatment technique under exclusive licence from Cardio Innovative Systems: N.O.logy®.
In order to amplify the mechanical forces responsible for the production of NO in our bodies, they designed a breakthrough innovation, the Pulsewave® suit, in combination with a console able to stimulate non-invasively and 100% naturally the endothelium inside our blood vessels.
The STENDO® technology is synchronised to the heartbeat of the patient and is based on the principle of mechanical compression and decompression at the surface of the skin. The consequence of this stimulation is the amplification of the pulses of blood, causing increased friction with the endothelial cells. This increases the natural production of NO, resulting in local and systemic effects throughout the body.
The N.O.logy® technique has no side effects, presenting new treatment possibilities and offering unprecedented solutions to health, beauty and well-being professionals.
STENDO has put in place a quality system to meet current regulatory standards governing the manufacture and sale of medical devices. This system is audited by SGS and has been certified as compliant with ISO 9001:2008 and ISO 13485:2003 standards.
ISO 13485 and ISO 9001 are international standards relating to quality management systems. The ISO 13485 standard specifies the specific requirements for quality management systems relating to the medical devices industry.
The Stendo device
developed for non-medical applications, is compliant with the CE marking for electrical devices.
The system is compliant with the following standards :
a) Electromagnetic Compatibility EMC
Directive 2004/108/EC, 2004 EMC ; EN IEC 60601-1-2:2007
b) Electrical Safety
The product has been tested to the IEC 60601-1:2005 standard
The tests were performed by the laboratory LCIE (Veritas)
The medical version of the STENDO device is subject to the medical devices directive 93/42/EC and should receive the relevant CE marking sometime in 2016, after an audit by a notified body: No. 0120 SGS.
Brands and patents filed worldwide.